Owens Corning 2017 Annual Report - s21.q4cdn.com

Unless the context indicates otherwise, the terms “Owens Corning,” “Company,” “we” and “our” in this 2017 Annual Report refer to Owens Corning and its subsidiaries.

  2017

Q1 FY17 Results & Acquisition of Multi Packaging …

3 Disclaimer; Non-GAAP Financial Measures We may from time to time be in possession of certain information regarding WestRock that applicable law would not

FORM 10-Q

Table of Contents FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements that involve a number of risks and uncertainties.

CORPORATE GOVERNANCE GUIDELINES - …

CORPORATE GOVERNANCE GUIDELINES As Approved by the Board of Directors on December 6, 2013 Responsibilities of the Board of Directors The Board of Directors, which is elected by the shareholders, is the ultimate decision-

  Guidelines, Governance, Corporate, Corporate governance guidelines

PFIZER INC. CORPORATE GOVERNANCE …

PFIZER INC. CORPORATE GOVERNANCE PRINCIPLES . Role and Composition of the Board of Directors . 1. General. The Board of Directors(the Board) , which is elected by the shareholders, is the

  Principles, Governance, Corporate, Roles, Compositions, Pfizer, Corporate governance, Corporate governance principles, Pfizer inc, Role and composition

ACCELERATING OUR GROWTH - s21.q4cdn.com

1 Veritiv Corporation is a Fortune 500® company and a leading North American business-to-business distributor of packaging, facility solutions, print and publishing products and services, and also a

  Veritiv

Amended and restated articles of incorporation of ...

Amended and restated articles of incorporation of Morningstar, Inc. ... FIRST (RESTATED): The name of the corporation is Morningstar, Inc. (hereinafter the "Corporation"). The Corporation was incorporated on May 16, 1984 as Mutual Fund Sourcebook, Inc. The Corporation amended its articles of incorporation on March 13, 1985 to change its name ...

  Article, Incorporation, Restated, Articles of incorporation, Morningstar, And restated articles of incorporation, And restated articles of incorporation of morningstar

Global Code Of Business Conduct and Ethics

The Global Code of Business Conduct and Ethics (Code) is designed to guide the conduct of all Principal employees, regardless of location, function or position, on ethical issues that are faced during the normal course of business.

  Code, Global, Conduct, Global code of

Global Code of Conduct - s21.q4cdn.com

Our Global Code of Conduct (Code) is an extension of all our core values, especially our core value of integrity. Integrity is defined as “the quality of possessing and steadfastly adhering to high moral principles or professional

  Code, Global, Conduct, Global code of conduct

Form 10-K 2009 FINAL - s21.q4cdn.com

1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One); ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the …

  Form, Annual, Report, Annual report, 2009, Form 10 k 2009

ACCREDO SPECIALTY MEDICATION LIST - Cigna

All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth Care Solutions, Inc., Evernorth

  Specialty, Cigna

ZEPOSIA U.S. Prescribing Information - BMS

ZEPOSIA is a sphingosine 1-phosphate receptor modulator indicated for the treatment of: • Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

  Zeposia

2020 Annual Report

and Zeposia (ozanimod). We added five new indications to our immuno-oncology portfolio, including four for our dual immunotherapy treatment, Opdivo (nivolumab) plus Yervoy (ipilimumab). Opdivo-based treatments are helping improve outcomes as first-line treatment for lung cancer patients

  Zeposia

170921 Oppdatering: Merkaptopurin (Puri-Nethol®) er lagt til

Ozanimod (Zeposia®) Prednisolon >= 20 mg daglig >1 mnd Risankizumab (Skyrizi®) Rituksimab (MabThera®, Rixathon®)2,3 Secukinumab (Cosentyx®) Sulfasalazin (Salazopyrin®) Takrolimus (Prograf®) Tocilizumab (RoActemra®) Tofacitinib (Xeljanz®) Upadacitinib (Rinvoq®) Ustekinumab (Stelara®) Vedolizumab (Entyvio®)

  Zeposia